Rebecca J. Sardell
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Predictive Value of Urine Tubular Biomarkers on Kidney Outcomes: Observations from EMPA-KIDNEY.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: May 15, 2026
Effects of Sacubitril/Valsartan versus Irbesartan on Urine Tubular Biomarkers in Chronic Kidney Disease: Findings from the UK HARP-III Trial.
Journal: American journal of nephrology
Published: January 26, 2026
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal: American journal of kidney diseases : the official journal of the National Kidney Foundation
Published: August 27, 2025
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Journal: Kidney international reports
Published: June 19, 2025
Effects of empagliflozin on conventional and exploratory acute and chronic kidney outcomes: an individual participant-level meta-analysis.
Journal: The lancet. Diabetes & endocrinology
Published: May 09, 2025
The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 15, 2024
Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: July 04, 2024
Frailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: February 22, 2024
Mechanisms of rosuvastatin-related acute kidney injury following cardiac surgery: the STICS trial.
Journal: European heart journal
Published: February 21, 2023
Interference of urinary albumin-to-creatinine ratio measurement by glycosuria: clinical implications when using SGLT-2 inhibitors.
Journal: Kidney international
Published: September 27, 2022
Fibroblast Growth Factor-23 and Risk of Cardiovascular Diseases: A Mendelian Randomization Study.
Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: April 27, 2022
Last Updated: 09/26/2026